Showing results (241-250 of 275) with videos related to
Sort By:
Pageof 28
Journal of Hepatology|July 2, 2011
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group reportHenry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, et al.Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.The Journal of Infectious Diseases|May 18, 2005
Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype CHenry L Y Chan, Stephen K W Tsui, Chi-Hang Tse, et al.Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Chronic hepatitis B: a critical appraisal of current approaches to therapyRobert P Perrillo, Robert G Gish, Marion Peters, et al.Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Pageof 28